Neuromodulation effectiveness on pain and quality of life

Assessment of effectiveness of closed loop spinal cord stimulation therapy on pain reduction and improvement of quality of life in patients suffering from chronic pain - Assessment of effectiveness of closed loop spinal cord stimulation

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON58057

Enrollment

Registered

2025-10-14

Start date

2023-05-01

Completion date

Unknown

Last updated

2025-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Persistent SPinal Pain syndrome type 2 Pain after spinal surgery

Interventions

EVOKE neuromodulation system

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Subject is deemed a suitable candidate for SCS trail and permanent implant and has been routinely scheduled to undergo an SCS trial phase with the Evoke SCS System.Subject is = 18 years old.Subject is not pregnant or nursing.Subject is willing and capable of giving informed consent

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
pain scorespromis 29 questionnaire	—

Secondary

Measure	Time frame
patient satisfaction	—

Countries

Netherlands

Contacts

Public ContactJ.L. Minkelis

Elisabeth-TweeSteden Ziekenhuis

jl.vandeminkelis@etz.nl0132216881

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)